18 Results for "

CMAS

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "CMAS" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-101106
CAS No.: 80306-38-3
Purity:  99.38%
Target:  

RAR/RXR

Research Areas:  

Neurological Disease Cancer

AR7 is an atypical RARA/RARα (retinoic acid receptor, alpha) antagonist. AR7 specifically activates chaperone-mediated-autophagy (CMA) activity without affecting macroautophagy .
8
8 Cited Publications
Cat. No.: HY-P1098
CAS No.: 151988-33-9
Target:  

Annexin A NF-κB

Research Areas:  

Inflammation/Immunology

Ac2-26 is the N-terminal peptide of annexin 1, and has anti-inflammatory activity. Ac2-26 induces a decrease in IKKβ protein in lysosomes by chaperone-mediated autophagy (CMA). Ac2-26 ameliorates lung ischemia-reperfusion injury. Ac2-26 also inhibits airway inflammation and hyperresponsiveness in an asthma rat model .
8
8 Cited Publications
Cat. No.: HY-P1098A
Target:  

Annexin A NF-κB

Research Areas:  

Inflammation/Immunology

Ac2-26 TFA is the N-terminal peptide of annexin 1, and has anti-inflammatory activity. Ac2-26 induces a decrease in IKKβ protein in lysosomes by chaperone-mediated autophagy (CMA). Ac2-26 ameliorates lung ischemia-reperfusion injury. Ac2-26 also inhibits airway inflammation and hyperresponsiveness in an asthma rat model .
8
8 Cited Publications
Cat. No.: HY-P1098B
Target:  

IKK

Research Areas:  

Inflammation/Immunology

Ac2-26 ammonium is the N-terminal peptide of annexin 1, and has anti-inflammatory activity. Ac2-26 ammonium induces a decrease in IKKβ protein in lysosomes by chaperone-mediated autophagy (CMA). Ac2-26 ammonium ameliorates lung ischemia-reperfusion injury. Ac2-26 ammonium also inhibits airway inflammation and hyperresponsiveness in an asthma rat model .
7
7 Cited Publications
Cat. No.: HY-134923
CAS No.: 2412270-22-3
Purity:  99.98%
Target:  

Autophagy

Research Areas:  

Neurological Disease

CA77.1 is a potent, brain-penetrant and orally active chaperone-mediated autophagy (CMA) activator with favorable pharmacokinetics. CA77.1 is a derivative of AR7 (HY-101106) and can increase the expression of the lysosomal receptor LAMP2A in?lysosomes. CA77.1 improves behavior and neuropathology in PS19 mice model and can be used for alzheimer's?disease research .
5
5 Cited Publications
Cat. No.: HY-112483
CAS No.: 1798331-92-6
Purity:  99.48%
Target:  

Autophagy

Research Areas:  

Cancer

QX77 is a chaperone-mediated autophagy (CMA) activator and upregulates LAMP2A expression in vitro. QX77 induces Rab11 upregulation, rescues Rab11 down-regulation and trafficking deficiency in cystinotic cells . QX77 can impede self-renewal and promote differentiation of ES cells .
2
2 Cited Publications
Cat. No.: HY-W013508
CAS No.: 106797-53-9
I2959 is widely used as a photoinitiator for photochemical cross-linking of hydrogels, and the combination of I2959 and CMA hydrogel has been used as a bio-ink for biological 3D printing applications. In addition, I2959 has a high free radical generation efficiency and is cytotoxic to rapidly dividing cell lines .
1
1 Cited Publications
Cat. No.: HY-155747
CAS No.: 2768426-49-7
Purity:  99.41%
Target:  

Autophagy Akt mTOR

Research Areas:  

Cancer

FDW028 a potent and highly selective FUT8 inhibitor. FUT8 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the chaperone-mediated autophagy (CMA) pathway. FDW028 can be used for metastatic colorectal cancer (mCRC) research .
Cat. No.: HY-112486
CAS No.: 1429321-13-0
Purity:  99.50%
Synonyms: Megakaryocytes/platelets inducing agent
TA-3166 (Megakaryocytes/platelets inducing agent) is a novel chemically synthesized c-MPL agonist (CMA) and thrombopoietin (TPO) receptor agonist. TA-316 enhances ex vivo platelet generation from human-induced pluripotent stem (iPS) cells .
Cat. No.: HY-RS02854
Research Areas:  

Others

CMAS Human Pre-designed siRNA Set A contains three designed siRNAs for CMAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS02853
Research Areas:  

Others

CMA1 Human Pre-designed siRNA Set A contains three designed siRNAs for CMA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS25804
Research Areas:  

Others

Cma1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cma1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-173150
CAS No.: 106928-29-4
Target:  

YAP

Hapalindole Q (Compound (+)-1) is an autophagy (Autophagy) inhibitor targeting YAP1. Hapalindole Q binds to the Hippo pathway transcription factor YAP1 with a Kd of 9.13 μM and induces its degradation via the chaperone-mediated autophagy (CMA) pathway. This process inhibits Rab7-mediated fusion of autophagosomes and lysosomes, thereby reducing overall autophagy levels without affecting lysosomal function. Hapalindole Q holds promise for research in cancer (e.g., liver cancer, breast cancer, etc.) .
Cat. No.: HY-RS22126
Research Areas:  

Others

Cmas Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cmas gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS28648
Research Areas:  

Others

Cmas Rat Pre-designed siRNA Set A contains three designed siRNAs for Cmas gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-101106R
CAS No.: 80306-38-3
Research Areas:  

Neurological Disease Cancer

AR7 (Standard) is the analytical standard of AR7 (HY-101106). This product is intended for research and analytical applications. AR7 is an atypical RARA/RARα (retinoic acid receptor, alpha) antagonist. AR7 specifically activates chaperone-mediated-autophagy (CMA) activity without affecting macroautophagy .
Cat. No.: HY-RS25439
Research Areas:  

Others

Mas1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mas1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.: HY-RS19313
Research Areas:  

Others

Cma1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cma1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

  • 1